Add BrightSurf on Google Email

Towards a better understanding of epigenetics and dynamic gene silencing and reactivation

A recent study by Nara Institute of Science and Technology reveals a new mechanism for dynamic gene silencing and reactivation, highlighting the intricate roles of proteins like SDG7. The research team identified a competitive interaction between SDGs and PRC2 at PREs, allowing for efficient gene activation through H3K36 methylation.

SourceNara Institute of Science and Technology·JournaleLife·TypeExperimental study·DateSep 10, 2024

Corn’s ‘missing link’

Researchers discover a gene drive system, Teosinte Pollen Drive (TPD), that enables the quick transfer of traits from teosinte to maize. This finding sheds light on corn's rapid adaptation to the highlands and has significant implications for agriculture.

SourceCold Spring Harbor Laboratory·JournalNature·DateAug 7, 2024

Hepatitis C leaves “scars” in immune cells even after successful treatment

Researchers found that the frequency of activated TREG cells remained elevated during treatment and continued to be high even after the virus was eliminated. Inflammatory features, such as increased TNF signaling, were sustained in TREG cells, indicating long-term immune system changes induced by the chronic infection.

SourceInstitute for Basic Science·JournalJournal of Hepatology·TypeExperimental study·DateJul 9, 2024

New class of cancer mutations discovered in so-called ‘junk’ DNA

A new study has identified potential cancer drivers hidden in so-called 'junk' regions of DNA, which could lead to early diagnosis and new treatments. The discovery reveals mutations in previously overlooked regions of the genome that may contribute to the formation and progression of at least 12 different cancers.

SourceGarvan Institute of Medical Research·JournalNucleic Acids Research·TypeExperimental study·DateJul 2, 2024

Depression, antidepressants, epigenetic age acceleration, and mortality in postmenopausal women

A new study reveals that depression and antidepressant use are associated with an increased risk of all-cause mortality in postmenopausal women. Epigenetic age acceleration, measured by GrimAge DNA methylation age acceleration, partially mediates the relationship between antidepressant use and increased mortality risk.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateJun 10, 2024

New test detects more cases of cervical cancer

A new molecular test WID-qCIN detects significantly more cancers and precancerous stages than current methods, identifying 100% of invasive cervical cancer and 93% of serious precancerous lesions. The test reduces the need for colposcopy examinations by 40%, improving the effectiveness of screening programs.

SourceKarolinska Institutet·JournalNature Medicine·DateJun 4, 2024

Research shows altered regulation of genes linked to prostate cancer among firefighters

A new study found that experienced firefighters have different epigenetic modifications linked to prostate cancer risk compared to new firefighters. Chemical exposure to PFAS is associated with these changes. The research team investigated fire department data and found a link between PFAS exposure and increased prostate cancer risk.

SourceUniversity of Arizona Health Sciences·JournalEnvironmental and Molecular Mutagenesis·DateMay 7, 2024

Mount Sinai researchers the first to apply single-cell analysis to reveal mechanisms of a common complication of Crohn’s disease

A study by Mount Sinai researchers has identified several pathophysiological mechanisms underlying perianal fistulae in Crohn’s disease. The findings highlight key transcription factor binding events and epigenetic phenomena that contribute to the higher rates of complications in African American patients. The research provides avenues...

Fontan circulation link to changes in the genetic code may lead to new treatment for heart conditions

Researchers found a link between Fontan circulation and accelerated epigenetic aging, which can cause complications like osteoporosis and renal impairment. The study suggests this acceleration starts in childhood and continues into adulthood, with potential new treatment opportunities to delay progression.

SourceUniversity of Birmingham·JournalJACC Advances·TypeObservational study·DateApr 4, 2024

Researchers find the key to genome-modifying drugs sensitivity in malignant blood diseases

A study by Dr Manel Esteller and colleagues identified an epigenetic signature associated with a good clinical response to hypomethylating drugs, enabling early detection of resistant patients. The research found single genes that facilitate the development of biomarkers and rescue strategies for non-responder patients.

SourceJosep Carreras Leukaemia Research Institute·JournalBritish Journal of Haematology·TypeExperimental study·DateMar 14, 2024

Study reveals the role of the protein Kdm1a in maintaining neuronal identity

A new study published in Nature Communications reveals that the Kdm1a protein is essential for preserving neuronal identity, and its loss or natural aging triggers the expression of genes that normally should not be expressed in neurons. The researchers found that eliminating this protein accelerates neuronal aging at an epigenetic level.

SourceUniversidad Miguel Hernandez de Elche·JournalNature Communications·TypeExperimental study·DateMar 12, 2024

Smoking has long-term effects on the immune system

A recent study published in Nature found that smoking has a lasting effect on the immune system, with certain defense mechanisms persisting for up to 10-15 years after quitting. The research used a large cohort of healthy volunteers and identified three key factors: smoking, latent cytomegalovirus infection, and body mass index.

SourceInstitut Pasteur·JournalNature·TypeData/statistical analysis·DateFeb 14, 2024

New study shows nutritional epigenetics education improves diet and attitude in parents of children with autism and ADHD

Parents who received nutritional epigenetics education reduced ultra-processed food consumption and increased whole organic foods intake, leading to improved behavior and cognition in their children. The education intervention also reduced heavy metal exposures and dietary deficits that disrupt gene function.

SourceFood Ingredient and Health Research Institute·JournalWorld Journal of Psychiatry·TypeRandomized controlled/clinical trial·DateFeb 9, 2024

Discovered how to predict whether patients with leukemia will be sensitive to epigenetic drugs

Researchers discovered a link between single cancer cell mutations and clinical response to epigenetic therapy in myelodysplastic syndrome. Patients showing treatment benefits had decreased mutation counts in stem cells and immature granulocytes, suggesting early tumor elimination is key to therapy success.

SourceJosep Carreras Leukaemia Research Institute·JournalCancer Research Communications·TypeExperimental study·DateFeb 5, 2024

Epigenetic combination therapy could overcome treatment resistance in epithelioid sarcomas and rhabdoid tumors

Researchers have identified mechanisms of resistance to tazemetostat in epithelioid sarcoma and rhabdoid tumors, leading to the development of a combination therapy strategy. The therapy uses an epigenetic treatment approach to target specific mutations that drive cancer growth.

SourceMemorial Sloan Kettering Cancer Center·JournalCancer Discovery·TypeExperimental study·DateFeb 5, 2024

Revisiting gene dosage

A study by Max Planck researchers has discovered an epigenetic regulator MSL2 that ensures the expression of both alleles of haploinsufficient genes, crucial for human health. This mechanism allows for tissue- and cell-type specificity in gene dosage, opening new directions for understanding diseases and developing potential treatments.

SourceMax Planck Institute of Immunobiology and Epigenetics·JournalNature·TypeExperimental study·DateNov 29, 2023

New target identified for pulmonary hypertension treatment

Researchers have identified a new therapeutic target for pulmonary hypertension treatment by discovering an epigenetic pathway mediated via the protein SPHK2 that can reduce and potentially reverse vascular remodeling. This discovery offers new hope for treating pulmonary hypertension, which is a complex and often fatal condition.

SourceIndiana University·JournalCirculation Research·DateNov 21, 2023

Copy number variation implements pregnancy as an aging model

Researchers found that pregnant mice experiencing copy number variation (CNV) showed similarities to aging, with biomarkers and genetic effects appearing during pregnancy and reversing after delivery. This study aims to revolutionize aging treatment by investigating the mechanisms behind post-labor rejuvenation.

SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateSep 6, 2023

Brigham researchers offer cohesive framework for evaluating biomarkers of aging

Researchers at Brigham and Women's Hospital have developed a cohesive framework for evaluating biomarkers of aging, providing a robust classification system for the identification and validation of molecular markers. The framework highlights key criteria for evaluation, including age-sensitivity and generalizability across cell types, ...

SourceBrigham and Women's Hospital·JournalCell·TypeLiterature review·DateAug 31, 2023

Editorial: Epigenetic aging in oocytes

The editorial discusses epigenetic mechanisms leading to oocyte quality loss, a significant factor in age-related fertility decline. Researchers highlight the importance of understanding this process to address the growing issue of advanced maternal age and its impact on reproduction.

SourceImpact Journals LLC·JournalAging-US·TypeCommentary/editorial·DateAug 30, 2023

Monell Center helps discover epigenetic mechanism that causes bitter taste distortion

Researchers found that inducing inflammation triggers an epigenetic response in Tas2r genes, leading to a decrease in sweet taste preference and potentially affecting appetite and medication tolerance. This study has significant clinical implications for understanding behavioral aspects of illness and developing effective bitter blockers.

SourceMonell Chemical Senses Center·JournaliScience·TypeExperimental study·DateAug 24, 2023

Study finds improved survival for incurable brain tumor, providing ‘a crack in the armor’

Researchers at Michigan Medicine have discovered a potential treatment for diffuse midline glioma, a type of childhood brain tumor with no effective treatments. The compound ONC201 nearly doubled survival rates in patients with the disease, and the underlying mechanism behind its success has been explained.

SourceMichigan Medicine - University of Michigan·JournalCancer Discovery·TypeRandomized controlled/clinical trial·DateAug 16, 2023